Health-Worker Risks of Catching Omicron Half as Likely after Fourth Dose – Second Israeli Study Challenges Earlier Results 21/01/2022 Maayan Hoffman In still evolving data, yet another Israeli study has found that health workers who received a fourth dose of a Pfizer mRNA vaccine were half as likely to contract Omicron seven days after receiving the shot in comparison to people who only got three doses. The study released Thursday came less than one week after […] Continue reading -> 105 Countries Set to Receive Generic Versions of New Merck Anti-COVID Drug, Molnupiravir 20/01/2022 Editorial team The Medicines Patent Pool (MPP) said Thursday that it had already signed agreements with 27 generic manufacturing companies for the manufacturing of the oral COVID-19 antiviral medication molnupiravir and supply in 105 low- and-middle-income countries (LMICs). The sublicense agreements are the result of the voluntary licensing agreement signed by MPP and MSD in October 2021 […] Continue reading -> France Approves COVID-19 Vaccine Pass Law, Joins Other EU Countries With COVID Fines and Mandates 17/01/2022 Raisa Santos France’s newest measure to tackle COVID-19 – requiring a certificate of vaccination at public places such as restaurants, cafes, cinemas, and long-distance trains – was approved by its parliament on Sunday. With lawmakers in the lower house of parliament voting 215 to 58 in favour, the law is set to be enforced in coming days. […] Continue reading -> COVAX Delivers One Billionth COVID-19 Vaccine Dose – But 41% of World Remains Unvaccinated 17/01/2022 Kerry Cullinan Rwanda became the recipient of the one-billionth COVID-19 vaccine delivered by COVAX, the global platform set up to ensure equitable access to the vaccines,announced last Friday. After numerous supply problems – most seriously when its key supplier, the Serum Insitute of India, was banned from exporting its vaccines by the Indian government – COVAX was […] Continue reading -> South Africa’s New COVID-19 Antigen Test is Able to Detect Omicron 12/01/2022 Kerry Cullinan CAPE TOWN – A locally produced COVID-19 rapid antigen test that was recently approved by South Africa’s medicines regulator is able to detect Omicron, according to its developer. This follows some controversy about whether antigen tests were able to detect Omicron, and suggestions that throat swabs might be more effective than nasal swabs as Omicron […] Continue reading -> International Summit on Disability and Health Aims to Achieve #HealthForAll 11/01/2022 Maayan Hoffman “Including the experiences and skills of people living with disabilities in the design and delivery of health systems is fundamental to achieving #HealthForAll,” wrote World Health Organization (WHO) Director-General Dr Tedros Adhanom Ghebreyesus on Twitter last week. Including the experiences & skills of people living with disabilities in the design & delivery of health systems […] Continue reading -> COVID-19 Vaccination Has Slight But ‘Clinically Insignificant’ Impact on Menstruation 07/01/2022 Maayan Hoffman Women who have been vaccinated against COVID-19 had a slight but not clinically significant change in the length of their menstrual cycles compared to unvaccinated women, according to a new study published by researchers from Oregon Health & Science University in Portland in Obstetrics & Gynecology. Specifically, vaccinated women experienced a less than one-day (0.71-day) […] Continue reading -> New Data on Side Effects of Second Pfizer Shot in Children Shows Fewer Adverse Effects than for Teens 04/01/2022 Maayan Hoffman Two new large scale reviews of the effects of the two-dose Pfizer’s mRNA vaccine in children aged 5-11 shows fewer severe effects than in older groups. Tuesday’s report, by the Israeli Health Fund Maccabi covering more than 20,000 children, comes on the heels of a similar US Centers for Disease Control and Prevention (CDC) study […] Continue reading -> US FDA Approves First Two Oral Anti-COVID Treatments: Pfizer’s Paxlovid & Merck’s Molnupiravir 23/12/2021 Zachary Brennan WASHINGTON D.C. (ENDPOINTS News) – The FDA on Thursday authorized another new pill to treat the Omicron variant, this time from Merck. The FDA decision follows upon a decision Wednesday authorizing Pfizer’s Paxlovid oral treatment, which the company said had proved to reduce the relative risk of hospitalization or death by 89% (within three days […] Continue reading -> Childhood Cancer Gets Massive Cash Investment to Boost Global Access to Medicine 13/12/2021 Raisa Santos A $200 million dollar investment – the largest financial commitment to addressing childhood cancer ever – has been announced by the World Health Organization (WHO) and US-based St Jude Children’s Research Hospital. The Global Platform for Access to Childhood Cancer Medicines will provide an uninterrupted supply of quality-assured cancer medicines to low- and middle-income countries. […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
105 Countries Set to Receive Generic Versions of New Merck Anti-COVID Drug, Molnupiravir 20/01/2022 Editorial team The Medicines Patent Pool (MPP) said Thursday that it had already signed agreements with 27 generic manufacturing companies for the manufacturing of the oral COVID-19 antiviral medication molnupiravir and supply in 105 low- and-middle-income countries (LMICs). The sublicense agreements are the result of the voluntary licensing agreement signed by MPP and MSD in October 2021 […] Continue reading -> France Approves COVID-19 Vaccine Pass Law, Joins Other EU Countries With COVID Fines and Mandates 17/01/2022 Raisa Santos France’s newest measure to tackle COVID-19 – requiring a certificate of vaccination at public places such as restaurants, cafes, cinemas, and long-distance trains – was approved by its parliament on Sunday. With lawmakers in the lower house of parliament voting 215 to 58 in favour, the law is set to be enforced in coming days. […] Continue reading -> COVAX Delivers One Billionth COVID-19 Vaccine Dose – But 41% of World Remains Unvaccinated 17/01/2022 Kerry Cullinan Rwanda became the recipient of the one-billionth COVID-19 vaccine delivered by COVAX, the global platform set up to ensure equitable access to the vaccines,announced last Friday. After numerous supply problems – most seriously when its key supplier, the Serum Insitute of India, was banned from exporting its vaccines by the Indian government – COVAX was […] Continue reading -> South Africa’s New COVID-19 Antigen Test is Able to Detect Omicron 12/01/2022 Kerry Cullinan CAPE TOWN – A locally produced COVID-19 rapid antigen test that was recently approved by South Africa’s medicines regulator is able to detect Omicron, according to its developer. This follows some controversy about whether antigen tests were able to detect Omicron, and suggestions that throat swabs might be more effective than nasal swabs as Omicron […] Continue reading -> International Summit on Disability and Health Aims to Achieve #HealthForAll 11/01/2022 Maayan Hoffman “Including the experiences and skills of people living with disabilities in the design and delivery of health systems is fundamental to achieving #HealthForAll,” wrote World Health Organization (WHO) Director-General Dr Tedros Adhanom Ghebreyesus on Twitter last week. Including the experiences & skills of people living with disabilities in the design & delivery of health systems […] Continue reading -> COVID-19 Vaccination Has Slight But ‘Clinically Insignificant’ Impact on Menstruation 07/01/2022 Maayan Hoffman Women who have been vaccinated against COVID-19 had a slight but not clinically significant change in the length of their menstrual cycles compared to unvaccinated women, according to a new study published by researchers from Oregon Health & Science University in Portland in Obstetrics & Gynecology. Specifically, vaccinated women experienced a less than one-day (0.71-day) […] Continue reading -> New Data on Side Effects of Second Pfizer Shot in Children Shows Fewer Adverse Effects than for Teens 04/01/2022 Maayan Hoffman Two new large scale reviews of the effects of the two-dose Pfizer’s mRNA vaccine in children aged 5-11 shows fewer severe effects than in older groups. Tuesday’s report, by the Israeli Health Fund Maccabi covering more than 20,000 children, comes on the heels of a similar US Centers for Disease Control and Prevention (CDC) study […] Continue reading -> US FDA Approves First Two Oral Anti-COVID Treatments: Pfizer’s Paxlovid & Merck’s Molnupiravir 23/12/2021 Zachary Brennan WASHINGTON D.C. (ENDPOINTS News) – The FDA on Thursday authorized another new pill to treat the Omicron variant, this time from Merck. The FDA decision follows upon a decision Wednesday authorizing Pfizer’s Paxlovid oral treatment, which the company said had proved to reduce the relative risk of hospitalization or death by 89% (within three days […] Continue reading -> Childhood Cancer Gets Massive Cash Investment to Boost Global Access to Medicine 13/12/2021 Raisa Santos A $200 million dollar investment – the largest financial commitment to addressing childhood cancer ever – has been announced by the World Health Organization (WHO) and US-based St Jude Children’s Research Hospital. The Global Platform for Access to Childhood Cancer Medicines will provide an uninterrupted supply of quality-assured cancer medicines to low- and middle-income countries. […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
France Approves COVID-19 Vaccine Pass Law, Joins Other EU Countries With COVID Fines and Mandates 17/01/2022 Raisa Santos France’s newest measure to tackle COVID-19 – requiring a certificate of vaccination at public places such as restaurants, cafes, cinemas, and long-distance trains – was approved by its parliament on Sunday. With lawmakers in the lower house of parliament voting 215 to 58 in favour, the law is set to be enforced in coming days. […] Continue reading -> COVAX Delivers One Billionth COVID-19 Vaccine Dose – But 41% of World Remains Unvaccinated 17/01/2022 Kerry Cullinan Rwanda became the recipient of the one-billionth COVID-19 vaccine delivered by COVAX, the global platform set up to ensure equitable access to the vaccines,announced last Friday. After numerous supply problems – most seriously when its key supplier, the Serum Insitute of India, was banned from exporting its vaccines by the Indian government – COVAX was […] Continue reading -> South Africa’s New COVID-19 Antigen Test is Able to Detect Omicron 12/01/2022 Kerry Cullinan CAPE TOWN – A locally produced COVID-19 rapid antigen test that was recently approved by South Africa’s medicines regulator is able to detect Omicron, according to its developer. This follows some controversy about whether antigen tests were able to detect Omicron, and suggestions that throat swabs might be more effective than nasal swabs as Omicron […] Continue reading -> International Summit on Disability and Health Aims to Achieve #HealthForAll 11/01/2022 Maayan Hoffman “Including the experiences and skills of people living with disabilities in the design and delivery of health systems is fundamental to achieving #HealthForAll,” wrote World Health Organization (WHO) Director-General Dr Tedros Adhanom Ghebreyesus on Twitter last week. Including the experiences & skills of people living with disabilities in the design & delivery of health systems […] Continue reading -> COVID-19 Vaccination Has Slight But ‘Clinically Insignificant’ Impact on Menstruation 07/01/2022 Maayan Hoffman Women who have been vaccinated against COVID-19 had a slight but not clinically significant change in the length of their menstrual cycles compared to unvaccinated women, according to a new study published by researchers from Oregon Health & Science University in Portland in Obstetrics & Gynecology. Specifically, vaccinated women experienced a less than one-day (0.71-day) […] Continue reading -> New Data on Side Effects of Second Pfizer Shot in Children Shows Fewer Adverse Effects than for Teens 04/01/2022 Maayan Hoffman Two new large scale reviews of the effects of the two-dose Pfizer’s mRNA vaccine in children aged 5-11 shows fewer severe effects than in older groups. Tuesday’s report, by the Israeli Health Fund Maccabi covering more than 20,000 children, comes on the heels of a similar US Centers for Disease Control and Prevention (CDC) study […] Continue reading -> US FDA Approves First Two Oral Anti-COVID Treatments: Pfizer’s Paxlovid & Merck’s Molnupiravir 23/12/2021 Zachary Brennan WASHINGTON D.C. (ENDPOINTS News) – The FDA on Thursday authorized another new pill to treat the Omicron variant, this time from Merck. The FDA decision follows upon a decision Wednesday authorizing Pfizer’s Paxlovid oral treatment, which the company said had proved to reduce the relative risk of hospitalization or death by 89% (within three days […] Continue reading -> Childhood Cancer Gets Massive Cash Investment to Boost Global Access to Medicine 13/12/2021 Raisa Santos A $200 million dollar investment – the largest financial commitment to addressing childhood cancer ever – has been announced by the World Health Organization (WHO) and US-based St Jude Children’s Research Hospital. The Global Platform for Access to Childhood Cancer Medicines will provide an uninterrupted supply of quality-assured cancer medicines to low- and middle-income countries. […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
COVAX Delivers One Billionth COVID-19 Vaccine Dose – But 41% of World Remains Unvaccinated 17/01/2022 Kerry Cullinan Rwanda became the recipient of the one-billionth COVID-19 vaccine delivered by COVAX, the global platform set up to ensure equitable access to the vaccines,announced last Friday. After numerous supply problems – most seriously when its key supplier, the Serum Insitute of India, was banned from exporting its vaccines by the Indian government – COVAX was […] Continue reading -> South Africa’s New COVID-19 Antigen Test is Able to Detect Omicron 12/01/2022 Kerry Cullinan CAPE TOWN – A locally produced COVID-19 rapid antigen test that was recently approved by South Africa’s medicines regulator is able to detect Omicron, according to its developer. This follows some controversy about whether antigen tests were able to detect Omicron, and suggestions that throat swabs might be more effective than nasal swabs as Omicron […] Continue reading -> International Summit on Disability and Health Aims to Achieve #HealthForAll 11/01/2022 Maayan Hoffman “Including the experiences and skills of people living with disabilities in the design and delivery of health systems is fundamental to achieving #HealthForAll,” wrote World Health Organization (WHO) Director-General Dr Tedros Adhanom Ghebreyesus on Twitter last week. Including the experiences & skills of people living with disabilities in the design & delivery of health systems […] Continue reading -> COVID-19 Vaccination Has Slight But ‘Clinically Insignificant’ Impact on Menstruation 07/01/2022 Maayan Hoffman Women who have been vaccinated against COVID-19 had a slight but not clinically significant change in the length of their menstrual cycles compared to unvaccinated women, according to a new study published by researchers from Oregon Health & Science University in Portland in Obstetrics & Gynecology. Specifically, vaccinated women experienced a less than one-day (0.71-day) […] Continue reading -> New Data on Side Effects of Second Pfizer Shot in Children Shows Fewer Adverse Effects than for Teens 04/01/2022 Maayan Hoffman Two new large scale reviews of the effects of the two-dose Pfizer’s mRNA vaccine in children aged 5-11 shows fewer severe effects than in older groups. Tuesday’s report, by the Israeli Health Fund Maccabi covering more than 20,000 children, comes on the heels of a similar US Centers for Disease Control and Prevention (CDC) study […] Continue reading -> US FDA Approves First Two Oral Anti-COVID Treatments: Pfizer’s Paxlovid & Merck’s Molnupiravir 23/12/2021 Zachary Brennan WASHINGTON D.C. (ENDPOINTS News) – The FDA on Thursday authorized another new pill to treat the Omicron variant, this time from Merck. The FDA decision follows upon a decision Wednesday authorizing Pfizer’s Paxlovid oral treatment, which the company said had proved to reduce the relative risk of hospitalization or death by 89% (within three days […] Continue reading -> Childhood Cancer Gets Massive Cash Investment to Boost Global Access to Medicine 13/12/2021 Raisa Santos A $200 million dollar investment – the largest financial commitment to addressing childhood cancer ever – has been announced by the World Health Organization (WHO) and US-based St Jude Children’s Research Hospital. The Global Platform for Access to Childhood Cancer Medicines will provide an uninterrupted supply of quality-assured cancer medicines to low- and middle-income countries. […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
South Africa’s New COVID-19 Antigen Test is Able to Detect Omicron 12/01/2022 Kerry Cullinan CAPE TOWN – A locally produced COVID-19 rapid antigen test that was recently approved by South Africa’s medicines regulator is able to detect Omicron, according to its developer. This follows some controversy about whether antigen tests were able to detect Omicron, and suggestions that throat swabs might be more effective than nasal swabs as Omicron […] Continue reading -> International Summit on Disability and Health Aims to Achieve #HealthForAll 11/01/2022 Maayan Hoffman “Including the experiences and skills of people living with disabilities in the design and delivery of health systems is fundamental to achieving #HealthForAll,” wrote World Health Organization (WHO) Director-General Dr Tedros Adhanom Ghebreyesus on Twitter last week. Including the experiences & skills of people living with disabilities in the design & delivery of health systems […] Continue reading -> COVID-19 Vaccination Has Slight But ‘Clinically Insignificant’ Impact on Menstruation 07/01/2022 Maayan Hoffman Women who have been vaccinated against COVID-19 had a slight but not clinically significant change in the length of their menstrual cycles compared to unvaccinated women, according to a new study published by researchers from Oregon Health & Science University in Portland in Obstetrics & Gynecology. Specifically, vaccinated women experienced a less than one-day (0.71-day) […] Continue reading -> New Data on Side Effects of Second Pfizer Shot in Children Shows Fewer Adverse Effects than for Teens 04/01/2022 Maayan Hoffman Two new large scale reviews of the effects of the two-dose Pfizer’s mRNA vaccine in children aged 5-11 shows fewer severe effects than in older groups. Tuesday’s report, by the Israeli Health Fund Maccabi covering more than 20,000 children, comes on the heels of a similar US Centers for Disease Control and Prevention (CDC) study […] Continue reading -> US FDA Approves First Two Oral Anti-COVID Treatments: Pfizer’s Paxlovid & Merck’s Molnupiravir 23/12/2021 Zachary Brennan WASHINGTON D.C. (ENDPOINTS News) – The FDA on Thursday authorized another new pill to treat the Omicron variant, this time from Merck. The FDA decision follows upon a decision Wednesday authorizing Pfizer’s Paxlovid oral treatment, which the company said had proved to reduce the relative risk of hospitalization or death by 89% (within three days […] Continue reading -> Childhood Cancer Gets Massive Cash Investment to Boost Global Access to Medicine 13/12/2021 Raisa Santos A $200 million dollar investment – the largest financial commitment to addressing childhood cancer ever – has been announced by the World Health Organization (WHO) and US-based St Jude Children’s Research Hospital. The Global Platform for Access to Childhood Cancer Medicines will provide an uninterrupted supply of quality-assured cancer medicines to low- and middle-income countries. […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
International Summit on Disability and Health Aims to Achieve #HealthForAll 11/01/2022 Maayan Hoffman “Including the experiences and skills of people living with disabilities in the design and delivery of health systems is fundamental to achieving #HealthForAll,” wrote World Health Organization (WHO) Director-General Dr Tedros Adhanom Ghebreyesus on Twitter last week. Including the experiences & skills of people living with disabilities in the design & delivery of health systems […] Continue reading -> COVID-19 Vaccination Has Slight But ‘Clinically Insignificant’ Impact on Menstruation 07/01/2022 Maayan Hoffman Women who have been vaccinated against COVID-19 had a slight but not clinically significant change in the length of their menstrual cycles compared to unvaccinated women, according to a new study published by researchers from Oregon Health & Science University in Portland in Obstetrics & Gynecology. Specifically, vaccinated women experienced a less than one-day (0.71-day) […] Continue reading -> New Data on Side Effects of Second Pfizer Shot in Children Shows Fewer Adverse Effects than for Teens 04/01/2022 Maayan Hoffman Two new large scale reviews of the effects of the two-dose Pfizer’s mRNA vaccine in children aged 5-11 shows fewer severe effects than in older groups. Tuesday’s report, by the Israeli Health Fund Maccabi covering more than 20,000 children, comes on the heels of a similar US Centers for Disease Control and Prevention (CDC) study […] Continue reading -> US FDA Approves First Two Oral Anti-COVID Treatments: Pfizer’s Paxlovid & Merck’s Molnupiravir 23/12/2021 Zachary Brennan WASHINGTON D.C. (ENDPOINTS News) – The FDA on Thursday authorized another new pill to treat the Omicron variant, this time from Merck. The FDA decision follows upon a decision Wednesday authorizing Pfizer’s Paxlovid oral treatment, which the company said had proved to reduce the relative risk of hospitalization or death by 89% (within three days […] Continue reading -> Childhood Cancer Gets Massive Cash Investment to Boost Global Access to Medicine 13/12/2021 Raisa Santos A $200 million dollar investment – the largest financial commitment to addressing childhood cancer ever – has been announced by the World Health Organization (WHO) and US-based St Jude Children’s Research Hospital. The Global Platform for Access to Childhood Cancer Medicines will provide an uninterrupted supply of quality-assured cancer medicines to low- and middle-income countries. […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
COVID-19 Vaccination Has Slight But ‘Clinically Insignificant’ Impact on Menstruation 07/01/2022 Maayan Hoffman Women who have been vaccinated against COVID-19 had a slight but not clinically significant change in the length of their menstrual cycles compared to unvaccinated women, according to a new study published by researchers from Oregon Health & Science University in Portland in Obstetrics & Gynecology. Specifically, vaccinated women experienced a less than one-day (0.71-day) […] Continue reading -> New Data on Side Effects of Second Pfizer Shot in Children Shows Fewer Adverse Effects than for Teens 04/01/2022 Maayan Hoffman Two new large scale reviews of the effects of the two-dose Pfizer’s mRNA vaccine in children aged 5-11 shows fewer severe effects than in older groups. Tuesday’s report, by the Israeli Health Fund Maccabi covering more than 20,000 children, comes on the heels of a similar US Centers for Disease Control and Prevention (CDC) study […] Continue reading -> US FDA Approves First Two Oral Anti-COVID Treatments: Pfizer’s Paxlovid & Merck’s Molnupiravir 23/12/2021 Zachary Brennan WASHINGTON D.C. (ENDPOINTS News) – The FDA on Thursday authorized another new pill to treat the Omicron variant, this time from Merck. The FDA decision follows upon a decision Wednesday authorizing Pfizer’s Paxlovid oral treatment, which the company said had proved to reduce the relative risk of hospitalization or death by 89% (within three days […] Continue reading -> Childhood Cancer Gets Massive Cash Investment to Boost Global Access to Medicine 13/12/2021 Raisa Santos A $200 million dollar investment – the largest financial commitment to addressing childhood cancer ever – has been announced by the World Health Organization (WHO) and US-based St Jude Children’s Research Hospital. The Global Platform for Access to Childhood Cancer Medicines will provide an uninterrupted supply of quality-assured cancer medicines to low- and middle-income countries. […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
New Data on Side Effects of Second Pfizer Shot in Children Shows Fewer Adverse Effects than for Teens 04/01/2022 Maayan Hoffman Two new large scale reviews of the effects of the two-dose Pfizer’s mRNA vaccine in children aged 5-11 shows fewer severe effects than in older groups. Tuesday’s report, by the Israeli Health Fund Maccabi covering more than 20,000 children, comes on the heels of a similar US Centers for Disease Control and Prevention (CDC) study […] Continue reading -> US FDA Approves First Two Oral Anti-COVID Treatments: Pfizer’s Paxlovid & Merck’s Molnupiravir 23/12/2021 Zachary Brennan WASHINGTON D.C. (ENDPOINTS News) – The FDA on Thursday authorized another new pill to treat the Omicron variant, this time from Merck. The FDA decision follows upon a decision Wednesday authorizing Pfizer’s Paxlovid oral treatment, which the company said had proved to reduce the relative risk of hospitalization or death by 89% (within three days […] Continue reading -> Childhood Cancer Gets Massive Cash Investment to Boost Global Access to Medicine 13/12/2021 Raisa Santos A $200 million dollar investment – the largest financial commitment to addressing childhood cancer ever – has been announced by the World Health Organization (WHO) and US-based St Jude Children’s Research Hospital. The Global Platform for Access to Childhood Cancer Medicines will provide an uninterrupted supply of quality-assured cancer medicines to low- and middle-income countries. […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
US FDA Approves First Two Oral Anti-COVID Treatments: Pfizer’s Paxlovid & Merck’s Molnupiravir 23/12/2021 Zachary Brennan WASHINGTON D.C. (ENDPOINTS News) – The FDA on Thursday authorized another new pill to treat the Omicron variant, this time from Merck. The FDA decision follows upon a decision Wednesday authorizing Pfizer’s Paxlovid oral treatment, which the company said had proved to reduce the relative risk of hospitalization or death by 89% (within three days […] Continue reading -> Childhood Cancer Gets Massive Cash Investment to Boost Global Access to Medicine 13/12/2021 Raisa Santos A $200 million dollar investment – the largest financial commitment to addressing childhood cancer ever – has been announced by the World Health Organization (WHO) and US-based St Jude Children’s Research Hospital. The Global Platform for Access to Childhood Cancer Medicines will provide an uninterrupted supply of quality-assured cancer medicines to low- and middle-income countries. […] Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Childhood Cancer Gets Massive Cash Investment to Boost Global Access to Medicine 13/12/2021 Raisa Santos A $200 million dollar investment – the largest financial commitment to addressing childhood cancer ever – has been announced by the World Health Organization (WHO) and US-based St Jude Children’s Research Hospital. The Global Platform for Access to Childhood Cancer Medicines will provide an uninterrupted supply of quality-assured cancer medicines to low- and middle-income countries. […] Continue reading -> Posts navigation Older Posts Newer Posts